High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era-Reference-Cited by-同舟云学术

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

Published:2011-12-06 Issue:5 Volume:53 Page:830-835
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ban-Hoefen Makiko,Kelly Jennifer L.,Bernstein Steven H.,Liesveld Jane,Constine Louis,Becker Michael,Milner Laurie,Phillips Gordon,Friedberg Jonathan W.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.631637

Reference33 articles.

1. New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

2. Improved Survival of Follicular Lymphoma Patients in the United States

3. Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

4. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

5. Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell Transplant;International Journal of Radiation Oncology*Biology*Physics;2022-07

2. Autologous stem cell transplant in first remission for transformed indolent non‐Hodgkin lymphoma: additional data to guide practice;British Journal of Haematology;2020-10-16

3. Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort;Leukemia & Lymphoma;2020-06-17

4. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma;Blood;2019-07-26

5. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019;Journal of the National Comprehensive Cancer Network;2019-06